Alexandra Dreyzin
Alexandra Dreyzin publishes mostly in Oncology, Public Health, Environmental and Occupational Health and Molecular Biology, on topics such as CAR-T cell therapy research, Acute Lymphoblastic Leukemia research and Childhood Cancer Survivors' Quality of Life.
- World rank
- #1,626,739 of 7,710,434 ranked researchers
- Rank in United States
- #505,271 of 1,627,098
- Works
- 51
- Citations
- 704
- Citations per work
- 13.8
What does Alexandra Dreyzin research?
Alexandra Dreyzin's work is mostly in Medicine (57%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2957.2%
- Medicine2957.2%
- Everything else1834.8%
- Life Sciences48.0%
- 1Oncology25% of their works
- 2Public Health, Environmental and Occupational Health14% of their works
- 3Molecular Biology8% of their works
- 4Genetics6% of their works
- 5Pediatrics, Perinatology and Child Health6% of their works
- 6Hematology6% of their works
Research topics
- CAR-T cell therapy research
- Acute Lymphoblastic Leukemia research
- Childhood Cancer Survivors' Quality of Life
- Viral Infectious Diseases and Gene Expression in Insects
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Immune Cell Function and Interaction
- Virus-based gene therapy research
Which keywords describe Alexandra Dreyzin's research?
The keywords of their largest research topics: Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Prognostic Factors, Acute Lymphoblastic Leukemia, Childhood Cancer, Rituximab and Childhood Cancer Survivor Study.
- Gene Therapy
- NK Cell Recognition
- Molecular Profiling
- Genomic Aberrations
- Chronic Lymphocytic Leukemia
- Childhood Cancer Survivor Study
- Childhood Cancer
- Prognostic Factors
- CAR T Cells
- Lymphoma
- Chimeric Antigen Receptor
- Acute Lymphoblastic Leukemia
- Rituximab
- Pediatric Quality of Life Inventory
- Classification
- Mammalian Cells
- Recombinant Protein
- Natural Killer Cells
- Viral Vectors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Lymphoma352 topics
- CAR T Cells301 topic
- Chimeric Antigen Receptor301 topic
- Prognostic Factors232 topics
- Acute Lymphoblastic Leukemia181 topic
- Childhood Cancer181 topic
- Rituximab102 topics
- Childhood Cancer Survivor Study61 topic
- Pediatric Quality of Life Inventory61 topic
- Chronic Lymphocytic Leukemia51 topic
- Classification51 topic
- Genomic Aberrations51 topic
- Mammalian Cells51 topic
- Molecular Profiling51 topic
- Recombinant Protein51 topic
- NK Cell Recognition41 topic
- Natural Killer Cells41 topic
- Gene Therapy31 topic
- Viral Vectors31 topic
Where does Alexandra Dreyzin work?
Alexandra Dreyzin's main affiliation in the publication record is National Institutes of Health, United States.
How many publications and citations does Alexandra Dreyzin have?
OpenAlex counts 51 works and 704 citations for Alexandra Dreyzin, an h-index of 12, ranking #1,626,739 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Alexandra Dreyzin. Posts are plain text and can be reported.